Department of Pediatrics I, Children's Hospital, University of Tübingen, Tübingen,
Roche Pharma Research and Early Development (pRED), Immunology, Inflammation and Infectious Diseases (I3) Discovery and Translational Area, Roche Innovation Center Basel, Basel,
J Innate Immun. 2018;10(5-6):487-501. doi: 10.1159/000487057. Epub 2018 Feb 13.
The respiratory tract is faced daily with 10,000 L of inhaled air. While the majority of air contains harmless environmental components, the pulmonary immune system also has to cope with harmful microbial or sterile threats and react rapidly to protect the host at this intimate barrier zone. The airways are endowed with a broad armamentarium of cellular and humoral host defense mechanisms, most of which belong to the innate arm of the immune system. The complex interplay between resident and infiltrating immune cells and secreted innate immune proteins shapes the outcome of host-pathogen, host-allergen, and host-particle interactions within the mucosal airway compartment. Here, we summarize and discuss recent findings on pulmonary innate immunity and highlight key pathways relevant for biomarker and therapeutic targeting strategies for acute and chronic diseases of the respiratory tract.
呼吸道每天要面对 10000 升吸入的空气。虽然大部分空气含有无害的环境成分,但肺部免疫系统还必须应对有害的微生物或无菌威胁,并迅速做出反应,以保护这个亲密的屏障区域中的宿主。气道具有广泛的细胞和体液宿主防御机制,其中大多数属于免疫系统的先天部分。常驻和浸润免疫细胞以及分泌的先天免疫蛋白之间的复杂相互作用,塑造了宿主-病原体、宿主-过敏原和宿主-颗粒在黏膜气道腔内相互作用的结果。在这里,我们总结和讨论了肺部先天免疫的最新发现,并强调了与呼吸道急性和慢性疾病的生物标志物和治疗靶向策略相关的关键途径。